Aytu BioPharma, Inc.
General ticker "AYTU" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $14.5M (TTM average)
Aytu BioPharma, Inc. follows the US Stock Market performance with the rate: 49.2%.
Estimated limits based on current volatility of 2.9%: low 2.53$, high 2.68$
Factors to consider:
- Total employees count: 102 (-32.0%) as of 2024
- US accounted for 99.9% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Lack of profitability, Strategic risks and growth management, Management distraction, Acquisition/divestiture risks, Market volatility
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [0.86$, 2.76$]
- 2026-06-30 to 2027-06-30 estimated range: [0.54$, 1.90$]
Financial Metrics affecting the AYTU estimates:
- Positive: with PPE of -3.8 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -15.05 <= 0.01
- Positive: Inventory ratio change, % of -1.01 <= -0.75
- Positive: Industry inventory ratio change (median), % of -0.87 <= -0.16
Short-term AYTU quotes
Long-term AYTU plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $109.34MM | $65.18MM | $66.38MM |
| Operating Expenses | $126.40MM | $66.77MM | $74.21MM |
| Operating Income | $-17.07MM | $-1.59MM | $-7.83MM |
| Non-Operating Income | $0.01MM | $-8.79MM | $-5.92MM |
| Interest Expense | $0.00MM | $4.79MM | $3.70MM |
| R&D Expense | $4.09MM | $2.77MM | $1.33MM |
| Income(Loss) | $-17.05MM | $-10.38MM | $-13.74MM |
| Taxes | $0.00MM | $2.14MM | $-0.44MM |
| Profit(Loss)* | $-17.05MM | $-15.84MM | $-13.56MM |
| Stockholders Equity | $39.36MM | $27.72MM | $18.97MM |
| Inventory | $11.99MM | $12.14MM | $11.43MM |
| Assets | $136.46MM | $118.86MM | $124.18MM |
| Operating Cash Flow | $-5.13MM | $-1.39MM | $-1.94MM |
| Capital expenditure | $0.00MM | $0.33MM | $3.23MM |
| Investing Cash Flow | $-0.12MM | $-0.33MM | $-2.56MM |
| Financing Cash Flow | $8.87MM | $-1.26MM | $15.44MM |
| Earnings Per Share** | $-5.11 | $-2.86 | $-2.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.